David Bouchey

Stock Analyst at Aegis Capital

(n/a)
# 4,841
Out of 4,854 analysts
6
Total ratings
n/a
Success rate
-60.18%
Average return

Stocks Rated by David Bouchey

Sunshine Biopharma
Dec 5, 2024
Reiterates: Buy
Price Target: $15
Current: $1.52
Upside: +886.84%
Sharps Technology
May 9, 2023
Initiates: Buy
Price Target: $105,600
Current: $5.87
Upside: +1,798,877.85%
Inspira Technologies Oxy B.H.N.
Jan 25, 2023
Maintains: Buy
Price Target: $10$13
Current: $0.73
Upside: +1,690.63%
Rockwell Medical
Oct 19, 2018
Downgrades: Outperform
Price Target: $121
Current: $1.01
Upside: +11,869.53%